OpenURL Connection Search

Select item for more details and to access through your institution.

Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells.
Published in:
Scientific Reports, 2017, p. 45954, doi. 10.1038/srep45954
By:
- Momeny, Majid;
- Sabourinejad, Zahra;
- Zarrinrad, Ghazaleh;
- Moghaddaskho, Farima;
- Eyvani, Haniyeh;
- Yousefi, Hassan;
- Mirshahvaladi, Shahab;
- Poursani, Ensieh M.;
- Barghi, Farinaz;
- Poursheikhani, Arash;
- Dardaei, Leila;
- Bashash, Davood;
- Ghazi-Khansari, Mahmoud;
- Tavangar, Seyyed M.;
- Dehpour, Ahmad R.;
- Yaghmaie, Marjan;
- Alimoghaddam, Kamran;
- Ghavamzadeh, Ardeshir;
- Ghaffari, Seyed H.
Publication type:
Article
Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells.
Published in:
Scientific Reports, 2017, p. 44075, doi. 10.1038/srep44075
By:
- Momeny, Majid;
- Moghaddaskho, Farima;
- Gortany, Narges K.;
- Yousefi, Hassan;
- Sabourinejad, Zahra;
- Zarrinrad, Ghazaleh;
- Mirshahvaladi, Shahab;
- Eyvani, Haniyeh;
- Barghi, Farinaz;
- Ahmadinia, Leila;
- Ghazi-Khansari, Mahmoud;
- Dehpour, Ahmad R.;
- Amanpour, Saeid;
- Tavangar, Seyyed M.;
- Dardaei, Leila;
- Emami, Amir H.;
- Alimoghaddam, Kamran;
- Ghavamzadeh, Ardeshir;
- Ghaffari, Seyed H.
Publication type:
Article
Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid Tumors.
Published in:
Cancers, 2023, v. 15, n. 1, p. 259, doi. 10.3390/cancers15010259
By:
- Pandya, Pankita H.;
- Jannu, Asha Jacob;
- Bijangi-Vishehsaraei, Khadijeh;
- Dobrota, Erika;
- Bailey, Barbara J.;
- Barghi, Farinaz;
- Shannon, Harlan E.;
- Riyahi, Niknam;
- Damayanti, Nur P.;
- Young, Courtney;
- Malko, Rada;
- Justice, Ryli;
- Albright, Eric;
- Sandusky, George E.;
- Wurtz, L. Daniel;
- Collier, Christopher D.;
- Marshall, Mark S.;
- Gallagher, Rosa I.;
- Wulfkuhle, Julia D.;
- Petricoin, Emanuel F.
Publication type:
Article
Precision Medicine Highlights Dysregulation of the CDK4/6 Cell Cycle Regulatory Pathway in Pediatric, Adolescents and Young Adult Sarcomas.
Published in:
Cancers, 2022, v. 14, n. 15, p. 3611, doi. 10.3390/cancers14153611
By:
- Barghi, Farinaz;
- Shannon, Harlan E.;
- Saadatzadeh, M. Reza;
- Bailey, Barbara J.;
- Riyahi, Niknam;
- Bijangi-Vishehsaraei, Khadijeh;
- Just, Marissa;
- Ferguson, Michael J.;
- Pandya, Pankita H.;
- Pollok, Karen E.
Publication type:
Article
Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for Osteosarcoma.
Published in:
Cancers, 2020, v. 12, n. 9, p. 2426, doi. 10.3390/cancers12092426
By:
- Pandya, Pankita H.;
- Cheng, Lijun;
- Saadatzadeh, M. Reza;
- Bijangi-Vishehsaraei, Khadijeh;
- Tang, Shan;
- Sinn, Anthony L.;
- Trowbridge, Melissa A.;
- Coy, Kathryn L.;
- Bailey, Barbara J.;
- Young, Courtney N.;
- Ding, Jixin;
- Dobrota, Erika A.;
- Dyer, Savannah;
- Elmi, Adily;
- Thompson, Quinton;
- Barghi, Farinaz;
- Shultz, Jeremiah;
- Albright, Eric A.;
- Shannon, Harlan E.;
- Murray, Mary E.
Publication type:
Article

Found: 5

Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells.

Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells.

Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid Tumors.

Precision Medicine Highlights Dysregulation of the CDK4/6 Cell Cycle Regulatory Pathway in Pediatric, Adolescents and Young Adult Sarcomas.

Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for Osteosarcoma.